The invention provides novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies where the compounds have the general formula (I), and G, X
1
, X
2
, R
1
, R
2
, R
3
, R
4
, R
4
′, R
5
, R
a
, R
b
, and R
c
are as described herein.